Table 4.
Clinical and pathological characteristics of breast and thyroid cancer patients
| Variable | Study population (n = 69) | p53-MCL positive (n = 2) |
|---|---|---|
| Age-years | ||
| Average | 60.2 | 58 |
| Range | 30–77 | 58–63 |
| Age onset Breast tumor appearance | ||
| Average | 49.1 | 48 |
| Range | 25–70 | 48–51 |
| Breast tumor Diagnosis | ||
| Ductal | 59 (85.5 %) | 1 (50 %) |
| Lobular | 3 (4.3 %) | 0 |
| Unknown | 7 (10.2 %) | 1 (50 %) |
| ER status | ||
| Negative | 17 (24.6 %) | 0 |
| Positive | 34 (49.3 %) | 2 (100 %) |
| Unknown | 18 (26.1 %) | 0 |
| PgR status | ||
| Negative | 17 (24.6 %) | 0 |
| Positive | 34 (49.3 %) | 2 (100 %) |
| Unknown | 18 (26.1 %) | 0 |
ER estrogen receptor, PgR progesterone receptor